PTC Therapeutics (PTCT) Misses Q3 EPS by 3c

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($0.93), $0.03 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $1.69 million versus the consensus estimate of $1.76 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Piper Sandler Reiterates Overweight Rating on KKR (KKR), 'highest conviction name'